Cystatins - Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells

Biochimie

Volumn 92, Issue 11, 2010, Pages 1625-1634

  Wallin, Hanna ^a   Bjarnadottir, Maria ^a   Vogel, Lotte K ^b   Wassélius, Johan ^a,c   Ekström, Ulf ^a   Abrahamson, Magnus ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cysteine peptidases; Cysteine protease inhibitors; Protein transport

Indexed keywords

CYSTATIN; CYSTATIN C; CYSTATIN D; CYSTATIN F; CYSTATIN G; CYSTATIN M; CYSTATIN S; CYSTATIN SA; CYSTATIN SN; CYSTEINE PROTEINASE INHIBITOR; HIGH MOLECULAR WEIGHT KININOGEN; LOW MOLECULAR WEIGHT KININOGEN; MUTANT PROTEIN; UNCLASSIFIED DRUG;

BODY FLUID; CELL SECRETION; CELL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXPRESSION VECTOR; EXTRACELLULAR FLUID; GENETIC TRANSFECTION; GENETIC VARIABILITY; HEREDITARY CYSTATIN C AMYLOID ANGIOPATHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTRACELLULAR FLUID; NEUROBLASTOMA CELL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; VASCULAR AMYLOIDOSIS; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE, TUMOR; CYSTATIN C; CYSTEINE PROTEASES; CYSTEINE PROTEINASE INHIBITORS; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SPACE; MICE; MUTATION; NEUROBLASTOMA; NIH 3T3 CELLS; PROTEIN TRANSPORT;

AVES; FUNGI; HEXAPODA; MAMMALIA; PROTOZOA;

EID: 78149361024     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.08.011     Document Type: Review

References (78)

1. Barrett A.J. Cystatin. Methods Enzymol. 1981, 80:771-778.
2. Rawlings N.D., Barrett A.J., Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010, 38:D227-D233.
3. Kordis D., Turk V. Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes. BMC Evol. Biol. 2009, 9:266.
4. Rawlings N.D., Barrett A.J. Evolution of proteins of the cystatin superfamily. J. Mol. Evol. 1990, 30:60-71.
5. Abrahamson M., Alvarez-Fernandez M., Nathanson C.-M. Cystatins. Biochem. Soc. Symp. 2003, 179-199.
6. Abrahamson M., Barrett A.J., Salvesen G., Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 1986, 261:11282-11289.
7. Ohkubo I., Kurachi K., Takasawa T., Shiokawa H., Sasaki M. Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. Biochemistry 1984, 23:5691-5697.
8. r kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem. J. 1986, 234:429-434.
9. Abrahamson M., Nathanson C.-M., Alvarez-Fernandez M. Human cystatins - similarities, diversity and classification. Human Stefins and Cystatins 2006, 1-21. Nova Biomedical Books, New York. E. Zerovnik, N. Kopitar-Jerala (Eds.).
10. Alvarez-Fernandez M., Abrahamson M. Structural and protease inhibitory features of cystatins. Human Stefins and Cystatins 2006, 23-42. Nova Biomedical Books, New York. E. Zerovnik, N. Kopitar-Jerala (Eds.).
11. Alvarez-Fernandez M., Barrett A.J., Gerhartz B., Dando P.M., Ni J., Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 1999, 274:19195-19203.
12. Abrahamson M., Grubb A., Olafsson I., Lundwall Å Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 1987, 216:229-233.
13. Schnittger S., Rao V.V., Abrahamson M., Hansmann I. Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2. Genomics 1993, 16:50-55.
14. Abrahamson M., Olafsson I., Palsdottir A., Ulvsbäck M., ÅLundwallJensson O., Grubb A. Structure and expression of the human cystatin C gene. Biochem. J. 1990, 268:287-294.
15. Thomas T., Schreiber G., Jaworowski A. Developmental patterns of gene expression of secreted proteins in brain and choroid plexus. Dev. Biol. 1989, 134:38-47.
16. Turk B., Turk D., Salvesen G.S. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Des. 2002, 8:1623-1637.
17. Olafsson I., Grubb A. Hereditary cystatin C amyloid angiopathy. Amyloid 2000, 7:70-79.
18. Freije J.P., Abrahamson M., Olafsson I., Velasco G., Grubb A., Lopez-Otin C. Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. J. Biol. Chem. 1991, 266:20538-20543.
19. Freije J.P., Balbin M., Abrahamson M., Velasco G., Dalbøge H., Grubb A., Lopez-Otin C. Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva. J. Biol. Chem. 1993, 268:15737-15744.
20. Alvarez-Diaz S., Valle N., Garcia J.M., Pena C., Freije J.M., Quesada V., Astudillo A., Bonilla F., Lopez-Otin C., Munoz A. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J. Clin. Invest. 2009, 119:2343-2358.
21. Ni J., Abrahamson M., Zhang M., Fernandez M.A., Grubb A., Su J., Yu G.L., Li Y., Parmelee D., Xing L., Coleman T.A., Gentz S., Thotakura R., Nguyen N., Hesselberg M., Gentz R. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J. Biol. Chem. 1997, 272:10853-10858.
22. Sotiropoulou G., Anisowicz A., Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J. Biol. Chem. 1997, 272:903-910.
23. Stenman G., Åström A.K., Roijer E., Sotiropoulou G., Zhang M., Sager R. Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridization. Cytogenet. Cell Genet. 1997, 76:45-46.
24. Zeeuwen P.L., van Vlijmen-Willems I.M., Jansen B.J., Sotiropoulou G., Curfs J.H., Meis J.F., Janssen J.J., van Ruissen F., Schalkwijk J. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J. Invest. Dermatol. 2001, 116:693-701.
25. Zeeuwen P.L., van Vlijmen-Willems I.M., Hendriks W., Merkx G.F., Schalkwijk J. A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification. Hum. Mol. Genet. 2002, 11:2867-2875.
26. Ni J., Fernandez M.A., Danielsson L., Chillakuru R.A., Zhang J., Grubb A., Su J., Gentz R., Abrahamson M. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J. Biol. Chem. 1998, 273:24797-24804.
27. Halfon S., Ford J., Foster J., Dowling L., Lucian L., Sterling M., Xu Y., Weiss M., Ikeda M., Liggett D., Helms A., Caux C., Lebecque S., Hannum C., Menon S., McClanahan T., Gorman D., Zurawski G. Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells. J. Biol. Chem. 1998, 273:16400-16408.
28. C-Nathanson M., Wasselius J., Wallin H., Abrahamson M. Regulated expression and intracellular localization of cystatin F in human U937 cells. Eur. J. Biochem. 2002, 269:5502-5511.
29. Langerholc T., Zavasnik-Bergant V., Turk B., Turk V., Abrahamson M., Kos J. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. FEBS J. 2005, 272:1535-1545.
30. Werle B., Sauckel K., Nathanson C.-M., Bjarnadottir M., Spiess E., Ebert W., Abrahamson M. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol. Chem. 2003, 384:281-287.
31. Hsia N., Cornwall G.A. CCAAT/enhancer binding protein beta regulates expression of the cystatin-related epididymal spermatogenic (Cres) gene. Biol. Reprod. 2001, 65:1452-1461.
32. Sloane B.F., Moin K., Krepela E., Rozhin J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metastasis Rev. 1990, 9:333-352.
33. Delaisse J.M., Eeckhout Y., Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem. Biophys. Res. Commun. 1984, 125:441-447.
34. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998, 93:1135-1145.
35. Levicar N., Strojnik T., Kos J., Dewey R.A., Pilkington G.J., Lah T.T. Lysosomal enzymes, cathepsins in brain tumour invasion. J. Neurooncol. 2002, 58:21-32.
36. Heidtmann H.H., Salge U., Abrahamson M., Bencina M., Kastelic L., Kopitar-Jerala N., Turk V., Lah T.T. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Clin. Exp. Metastasis 1997, 15:368-381.
37. Keppler D., Sameni M., Moin K., Mikkelsen T., Diglio C.A., Sloane B.F. Tumor progression and angiogenesis: cathepsin B & Co. Biochem. Cell Biol. 1996, 74:799-810.
38. Corticchiato O., Cajot J.F., Abrahamson M., Chan S.J., Keppler D., Sordat B. Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation. Int. J. Cancer 1992, 52:645-652.
39. Cox J.L., Sexton P.S., Green T.J., Darmani N.A. Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res. 1999, 9:369-374.
40. Sexton P.S., Cox J.L. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C. Melanoma Res. 1997, 7:97-101.
41. Coulibaly S., Schwihla H., Abrahamson M., Albini A., Cerni C., Clark J.L., Ng K.M., Katunuma N., Schlappack O., Glössl J., Mach L. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int. J. Cancer 1999, 83:526-531.
42. Shridhar R., Zhang J., Song J., Booth B.A., Kevil C.G., Sotiropoulou G., Sloane B.F., Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 2004, 23:2206-2215.
43. Zhang J., Shridhar R., Dai Q., Song J., Barlow S.C., Yin L., Sloane B.F., Miller F.R., Meschonat C., Li B.D., Abreo F., Keppler D. Cystatin M: a novel candidate tumor suppressor gene for breast cancer. Cancer Res. 2004, 64:6957-6964.
44. Qiu J., Ai L., Ramachandran C., Yao B., Gopalakrishnan S., Fields C.R., Delmas A.L., Dyer L.M., Melnick S.J., Yachnis A.T., Schwartz P.H., Fine H.A., Brown K.D., Robertson K.D. Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas. Lab. Invest. 2008, 88:910-925.
45. Briggs J.J., Haugen M.H., Johansen H.T., Riker A.I., Abrahamson M., Fodstad O., Maelandsmo G.M., Solberg R. Cystatin E/M suppresses legumain activity and invasion of human melanoma. BMC Cancer 2010, 10:17.
46. Ekström U., Wallin H., Lorenzo J., Holmqvist B., Abrahamson M., Aviles F.X. Internalization of cystatin C in human cell lines. FEBS J. 2008, 275:4571-4582.
47. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 1978, 38:3751-3757.
48. Rettig W.J., Spengler B.A., Chesa P.G., Old L.J., Biedler J.T. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 1987, 47:1383-1389.
49. Abrahamson M., Dalbøge H., Olafsson I., Carlsen S., Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett. 1988, 236:14-18.
50. Sheikh S.P., O'Hare M.M., Tortora O., Schwartz T.W. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines. J. Biol. Chem. 1989, 264:6648-6654.
51. Olafsson I., Löfberg H., Abrahamson M., Grubb A. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand. J. Clin. Lab. Invest. 1988, 48:573-582.
52. Bjarnadottir M., Grubb A., Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand. J. Clin. Lab. Invest. 1995, 55:617-623.
53. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
54. Hall A., Håkansson K., Mason R.W., Grubb A., Abrahamson M. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J. Biol. Chem. 1995, 270:5115-5121.
55. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
56. Bjarnadottir M., Wulff B.S., Sameni M., Sloane B.F., Keppler D., Grubb A., Abrahamson M. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. Mol. Pathol. 1998, 51:317-326.
57. Thorsteinsson L., Georgsson G., Asgeirsson B., Bjarnadottir M., Olafsson I., Jensson O., Gudmundsson G. On the role of monocytes/macrophages in the pathogenesis of central nervous system lesions in hereditary cystatin C amyloid angiopathy. J. Neurol. Sci. 1992, 108:121-128.
58. Keppler D., Abrahamson M., Sordat B. Secretion of cathepsin B and tumour invasion. Biochem. Soc. Trans. 1994, 22:43-49.
59. Ebert E., Werle B., Julke B., Kopitar-Jerala N., Kos J., Lah T., Abrahamson M., Spiess E., Ebert W. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. Adv. Exp. Med. Biol. 1997, 421:259-265.
60. Jensson O., Gudmundsson G., Arnason A., Blöndal H., Petursdottir I., Thorsteinsson L., Grubb A., Löfberg H., Cohen D., Frangione B. Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol. Scand. 1987, 76:102-114.
61. Ghiso J., Jensson O., Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc. Natl. Acad. Sci. U.S.A. 1986, 83:2974-2978.
62. Palsdottir A., Abrahamson M., Thorsteinsson L., Arnason A., Olafsson I., Grubb A., Jensson O. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988, 2:603-604.
63. Benedikz E., Merz G.S., Schwenk V., Johansen T.E., Wisniewski H.M., Rushbrook J.I. Cellular processing of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. Amyloid 1999, 6:172-182.
64. Wei L., Berman Y., Castano E.M., Cadene M., Beavis R.C., Devi L., Levy E. Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyoidosis, Iceandic type. J. Biol. Chem. 1998, 273:11806-11814.
65. Merz G.S., Benedikz E., Schwenk V., Johansen T.E., Vogel L.K., Rushbrook J.I., Wisniewski H.M. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J. Cell. Physiol. 1997, 173:423-432.
66. Gerhartz B., Ekiel I., Abrahamson M. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry 1998, 37:17309-17317.
67. Ekiel I., Abrahamson M. Folding-related dimerization of human cystatin C. J. Biol. Chem. 1996, 271:1314-1321.
68. Ekiel I., Abrahamson M., Fulton D.B., Lindahl P., Storer A.C., Levadoux W., Lafrance M., Labelle S., Pomerleau Y., Groleau D., LeSauteur L., Gehring K. NMR structural studies of human cystatin C dimers and monomers. J. Mol. Biol. 1997, 271:266-277.
69. Janowski R., Kozak M., Jankowska E., Grzonka Z., Grubb A., Abrahamson M., Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 2001, 8:316-320.
70. Abrahamson M., Grubb A. Increased body temperature accelerates aggregation of the Leu-68→Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:1416-1420.
71. Gerhartz B., Abrahamson M. Physico-chemical properties of the N-terminally truncated L68Q cystatin C found in amyloid deposits of brain haemorrhage patients. Biol. Chem. 2002, 383:301-305.
72. Löfberg H., Grubb A.O., Jörnvall H., Möller C.A., Strömblad L.G., Olsson S.O. Gamma-trace in human pituitary adenomas. J. Clin. Endocrinol. Metab. 1984, 59:113-118.
73. Löfberg H., Grubb A.O., Nilsson E.K., Jensson O., Gudmundsson G., Blöndal H., Arnason A., Thorsteinsson L. Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke 1987, 18:431-440.
74. Håkansson K., Huh C., Grubb A., Karlsson S., Abrahamson M. Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1996, 114:303-311.
75. Sokol J.P., Schiemann W.P. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol. Cancer Res. 2004, 2:183-195.
76. Ross R.A., Biedler J.L., Spengler B.A. A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett. 2003, 197:35-39.
77. Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.F., Biedler J.L., Cheung N.K., Ross R.A. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6:838-845.
78. Keppler D., Waridel P., Abrahamson M., Bachmann D., Berdoz J., Sordat B. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim. Biophys. Acta 1994, 1226:117-125.